Drug Type Biological products |
Synonyms OMTX 707, OMTX-707 |
Target |
Action inhibitors |
Mechanism Tubulin inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Fibrosis | Preclinical | Spain | 01 Apr 2025 | |
| Sarcoma | Preclinical | Spain | 01 Apr 2025 | |
| Solid tumor | Preclinical | Spain | 01 Apr 2025 | |
| Breast Cancer | Preclinical | United States | - | |
| Lung Cancer | Preclinical | United States | - | |
| Ovarian Epithelial Carcinoma | Preclinical | United States | - | |
| Pancreatic Cancer | Preclinical | United States | - | |
| Prostatic Cancer | Preclinical | United States | - |





